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Hydroxytyrosol (HT), a virgin olive oil phenolic phytochemical with proven health beneﬁts, has been used to
generate new lipophilic antioxidants to preserve fats and oils against autoxidation. The aim of this work is to
comparatively evaluate the physiological eﬀects of HT and its lipophilic derivatives, hydroxytyrosyl acetate
(HT-Ac) and ethyl hydroxytyrosyl ether (HT-Et), in high-cholesterol fed animals. Male Wistar rats (n ¼ 8)
were fed a standard diet (C group), a cholesterol-rich diet (Chol group) or a cholesterol-rich diet
supplemented with phenolic compounds (HT group, HT-Ac group and HT-Et group) for 8 weeks. Body
and tissue weights, the lipid proﬁle, redox status, and biochemical, hormonal, and inﬂammatory
biomarkers were evaluated. Plasma levels of total cholesterol, LDL cholesterol, glucose, insulin and
leptin, as well as malondialdehyde in serum increased in Chol compared to C (p < 0.05). Rats fed the test
diets had improved glucose, insulin, leptin and MDA levels and antioxidant capacity status, with HT-Ac
being the most eﬀective compound. The studied phenolic compounds also modulated TNF-a and IL-1b
plasma levels compared to Chol. HT-Ac and HT-Et improved adipose tissue distribution and adipokine
production, decreasing MCP-1 and IL-1b levels. Our results conﬁrm the metabolic eﬀects of HT, which
are maintained and even improved by hydrophobic derivatives, particularly HT-Ac.1. Introduction
The most representative phenolic compound in virgin olive oil,
hydroxytyrosol (HT), plays an important role in the prevention
of degenerative diseases.1,2 Explicitly, it is involved in the
reduction of LDL oxidation, a well-known cardiovascular risk
factor,3 and is transiently associated with LDL lipoproteins.4
Moreover, HT is involved in the inhibition of lipid and protein
oxidation in human plasma,5 having anti-inammatory6 and
antiplatelet aggregation properties.7 Additionally, there is
evidence that olive oil phenolic compounds decrease plasma
glucose levels in rats.8,9 HT can be eﬃciently recovered from
olive by-products, which has prompted the study of the bio-
logical and health eﬀects of HT from alperujo8,10 or olive
leaves.9,11
On the other hand, the food industry demands new lipo-
philic antioxidants to preserve fats and oils againstIdiPaz), Madrid, Spain
, Instituto de Ciencia y Tecnolog´ıa de
ntonio Novais 10, Ciudad Universitaria,
os@ictan.csic.es; Fax: +34 91 549 36 27;
Facultad de Farmacia, Universidad deautoxidation. Two series of hydrophobic derivatives of HT,
hydroxytyrosyl esters12 and hydroxytyrosyl ethers,13 have been
synthesized. Hydroxytyrosyl acetate (HT-Ac) merits special
interest among hydroxytyrosyl esters, since it is an antioxidant
naturally present in virgin olive oil14 that is transported across
the small intestinal epithelial cell barrier more eﬃciently than
HT,15 showing higher hepatic bioavailability than HT.16 More-
over, HT-Ac has shown protective eﬀects against oxidative DNA
damage in blood cells,17 iron-induced oxidative stress in human
cervical cells,18 and oxidative stress in HepG2 cells.19 Hydrox-
ytyrosyl ethyl ether (HT-Et), with an alkyl chain of the same
length as the acyl chain in HT-Ac, was included in this study to
assess the inuence of diﬀerent functional groups (ether-
ication versus esterication) on the biological activity of the
two phenolic compounds. HT-Et is absorbed to a higher extent
in Caco-2 cells than its precursor HT,20 with an absorption rate
similar to that of HT-Ac,15 being also broadly taken up by HepG2
cells.21 In addition, HT-Et protects hepatic human HepG2 cells
against oxidative stress22 and inhibits platelet activation aer
oral administration in rats.23 These antecedents justify using
this compound although it is not naturally present in virgin
olive oil.
Both HT-Ac and HT-Et maintain the orthodiphenolic group
intact and show higher antioxidant capacity than HT,24,25This journal is © The Royal Society of Chemistry 2014
Paper Food & Function
Pu
bl
ish
ed
 o
n 
23
 M
ay
 2
01
4.
 D
ow
nl
oa
de
d 
by
 In
sti
tu
to
 d
e 
Ci
en
ci
a 
y 
Te
cn
ol
og
ia
 d
e 
A
lim
en
to
s y
 N
ut
ric
io
n 
(IC
TA
N)
 on
 30
/09
/20
14
 10
:27
:43
. 
View Article Onlinepreserving their potential application as antioxidants to stabi-
lize foodstuﬀs or as functional food ingredients.
Keeping these in mind, the aim of the present study is to
comparatively analyse the ability of HT and its lipophilic
derivatives, HT-Ac and HT-Et, counteracting the metabolic
deregulation derived from consuming a high-cholesterol diet,
focusing on the eﬀects on plasma lipids, glucose levels,
hormone response, oxidative stress and pro-inammatory
status. In addition, body weight gain, adipose tissue distribu-
tion and secretion of adipokines from visceral fat were
evaluated.2. Experimental
2.1. Materials and chemicals
Cholesterol, cholic acid, palmitic acid, 6-hydroxy-2,5,7,8-tetrame-
thylchroman-2-carboxilic acid (Trolox), 1,1,3,3-tetraethoxypropane,
uorescein, 2,20-azobis(2-amidinopropane) dihydrochloride
(AAPH), trizma base, dithiothreitol, and 2,4-dinitrophenylhy-
drazine were purchased from Sigma-Aldrich Chemical (Madrid,
Spain). Sodium hydroxide, sulphuric acid, sodium hydrogen
phosphate and potassium dihydrogen phosphate were from Pan-
reac (Madrid, Spain). The Bradford reagent was from BioRad
(BioRad Laboratories S.A., Madrid, Spain). Free fatty acids (FFA)
colorimetric kit was purchased from Roche (Roche Applied
Science, Madrid Spain). Rat adipocyte (RADPCYT-82K, Milliplex
Map Rat Adipocyte Panel) and adipokine (RADPK-81K, Milliplex
Map Kit Rat Serum Adipokine Panel) Milliplex kits were acquired
from Millipore (Millipore, Billerica, MA, US, USA). Other reagents
were of analytical or chromatographic quality.
HT was isolated with 98% purity from olive oil waste water
following a patented procedure26 and further puried by
column chromatography.
HT-Ac was obtained from HT in ethyl acetate aer incuba-
tion with p-toluenesulfonic acid and purication by column
chromatography following a patented procedure.12
HT-Et was obtained from HT by chemical synthesis as
described elsewhere.13Table 1 Dietary composition of experimental diets
Component
(g per 100 g dry weight) C Chol HT HT-Ac HT-Et
Carbohydrates 65.93 64.20 64.17 64.17 64.17
Protein 17.58 17.12 17.11 17.11 17.11
Lipids (other than
cholesterol)
3.30 3.21 3.21 3.21 3.21
Cholesterol 0.00 2.19 2.19 2.19 2.19
Cholic acid 0.00 0.44 0.44 0.44 0.44
HT and derivatives 0.00 0.00 0.04 0.04 0.04
Caloric content
(kcal per 100 g)
219.2 227.7 227.7 227.7 227.72.2. Diet, animals and experimental design
Forty male Wistar rats (200–225 g body weight) were purchased
from an accredited supplier (Charles River Laboratorios
Espan˜a, S.A. Barcelona, Spain) and housed in metabolic cages.
They had free access to food and water, and were maintained
under a normal light–dark cycle in the Experimental Surgery
Service of La Paz University Hospital (registration number:
280790001941). Aer one week of acclimation, animals were
randomly distributed into 5 diﬀerent experimental groups
(8 rats per group). One group received the standard, mainte-
nance rodent diet (A04-SAFE, Augy, France), which is the control
(C group), and four groups were fed the standard diet supple-
mented with 2% cholesterol and 0.4% cholic acid in order to
generate the hypercholesterolemic model as described else-
where.27 In three of these groups, the hypercholesterolemic diet
was supplemented with 0.04% of HT (HT group), HT-Ac (HT-Ac
group) and HT-Et (HT-Et group), respectively, to assess theThis journal is © The Royal Society of Chemistry 2014potential benecial eﬀects of these phenolic compounds on the
hypercholesterolemic rat model. Nutritional and energetic
content of each diet is summarized in Table 1. During the whole
intervention, animal health status and dietary tolerance were
monitored by veterinary individual observation in addition to
weekly control of animals' weight (Table 2). Aer 8 weeks,
animals were subjected to complete exsanguination under
general anesthesia (isourane 2%). Plasma and serum fractions
were separated by centrifugation (10 minutes at 2500 g) using
pretreated EDTA or Silica Act Cot Activator blood collection
tubes (BD Vacutainer, Plymouth, UK), respectively, and stored at
20 C until further analysis. Liver, kidney, heart and adipose
tissue from retroperitoneal and epididymal areas were
collected, weighed and washed with ice-cold phosphate buﬀ-
ered saline. Samples were immediately frozen in liquid nitrogen
and stored at 80 C until analysis. The study protocol was
approved by the Institutional Animal Ethics Committee of La
Paz University Hospital (Madrid, Spain) and procedures were
performed in accordance with the Spanish law for the protec-
tion of experimental animals (RD 53/2013, BOE no 34 Sec I pg
11370 8th February 2013).2.3. Blood biochemical analyses
Triglycerides, total cholesterol, LDL cholesterol, HDL choles-
terol, glucose and creatinine in plasma were determined using
an automated analyser (Beckman Coulter-Former Olympus
Diagnostics AU 5420, Nyon, Switzerland). Plasma free fatty acid
(FFA) concentration was determined with a colorimetric
commercial assay kit (Free Fatty Acids, Half Micro Test, Roche
Applied Science) using palmitic acid as standard.2.4. Determination of oxygen radical scavenging capacity
(ORAC) in serum
Serum antioxidant activity was analysed using the hydrophilic
oxygen radical scavenging capacity (ORAC) assay according to
the method developed by Huang, Ou, Hampsch-Woodill, Fla-
nagan & Prior.28 The uorescence at 485 and 528 nm excitation
and emission wavelengths, respectively, was determined in a 96-
well microplate reader (Bio-Tek, Winooski, VT, USA). ORAC
values were expressed as micromoles of Trolox mL1 serum.Food Funct., 2014, 5, 1556–1563 | 1557
Table 2 Body and tissue weights of rats in the control group (C), the group consuming the non-supplemented cholesterol-rich diet (Chol) or the
cholesterol-rich diet supplemented with hydroxytyrosol (HT), hydroxytyrosyl acetate (HT-Ac) and ethyl hydroxytyrosyl ether (HT-Et). Data
represent the mean of 8 determinations  SD*
Standard diet Hypercholesterolemic diet
C Chol HT HT-Ac HT-Et
Body weight (g)
Initial 242 + 6 244 + 8 244 + 7 239 + 11 243 + 4
Final 336 + 18 326 + 30 331 + 16 317 + 10 329 + 14
Body weight gain (g per 56 day) 94 + 15 82 + 32 87 + 12 78 + 11 86 + 12
Tissue weights (g)
Epididymal fat/body weight 0.016 + 0.003 0.016 + 0.002 0.015 + 0.001 0.017 + 0.003 0.015 + 0.004
Retroperitoneal fat/body weight 0.018 + 0.004 0.015 + 0.002 0.014 + 0.002 0.017 + 0.001 0.016 + 0.005
Ratio retroperitoneal/epididymal 0.88 + 0.09a 1.07 + 0.08b 1.07 + 0.08b 1.00 + 0.05ab 0.93 + 0.07ab
Liver/body weight 0.024 + 0.002a 0.038 + 0.003b 0.029 + 0.018ab 0.036 + 0.002b 0.037 + 0.002b
Kidney/body weight 0.0053 + 0.0022 0.0057 + 0.0005 0.0058 + 0.0008 0.0061 + 0.0005 0.0059 + 0.0006
Heart/body weight 0.0026 + 0.0003 0.0028 + 0.0005 0.0025 + 0.0001 0.0029 + 0.0005 0.0028 + 0.0003
* Mean values in a row with unlike superscripts are signicantly diﬀerent according to Kruskal–Wallis one-way analysis of variance and Mann–
Whitney U test (p < 0.05).
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View Article Online2.5. Determination of malondialdehyde (MDA) in serum and
liver
MDA was determined as its hydrazone by high-performance
liquid chromatography using 2,4-dinitrophenylhydrazine for
derivatization.29 Livers (0.5 g) were homogenized (1 : 5 w/v) in
ice-cold 0.25 M Trizma base buﬀer pH 7.4 containing 5 mM
dithiothreitol using an Ultra Turrax (IKA® Works Inc., Wil-
mingtonNC) at 18 000 rpm. Aer centrifugation (11 000 rpm 30
min, 4 C), supernatants were collected for MDA quantication.
Serum samples were analysed directly. Standard MDA was
prepared by acidic hydrolysis of 1,1,3,3-tetraethoxypropane in
1% sulphuric acid. Concentrations were expressed as nano-
moles of MDA per milligram of protein in liver tissue and per
millilitre in serum. The protein content in liver homogenates
was estimated by the Bradford method using a Bio-Rad protein
assay kit.2.6. Determination of cytokines and hormones in plasma
and adipose tissue by immunoassay
A sample of white adipose tissue from the retroperitoneal area
(0.2 g) was collected and homogenized (1 : 3.5 w/v) in PBS (pH
7.4) with Triton X-100 and protease inhibitor by low tempera-
ture sonication (17 microns, 3 consecutive pulses of 15 seconds
at 30 seconds interval). Aer centrifugation (5000 rpm, 10 min,
4 C), the lipid layer was removed and supernatants were
collected for adipokine determination. The concentrations of
leptin, interleukin-1b (IL-1b), interleukin-6 (IL-6), tumour
necrosis factor-a (TNF-a), monocyte chemoattractant protein-1
(MCP-1) and plasminogen activator inhibitor-1 (PAI-1) in the
retroperitoneal adipose tissue were determined using a Rat
Adipocyte Multiplex Kit (RADPCYT-82K Milliplex Map Kit, Rat
Adipocyte Panel, Millipore, Billerica, MA, US). IL-1b, IL-6, TNF-
a, insulin and leptin concentrations were determined in plasma
samples obtained at the end of the intervention using a Rat1558 | Food Funct., 2014, 5, 1556–1563Adipokine multiplex kit (RADPK-81K, Milliplex Map Kit, Rat
Serum Adipokine Panel, Millipore, Billerica, MA, US). Multi-
analyte proling panels were used according to manufacturer's
instructions and analysed on a LuminexLX200 Analyzer. Data
were analysed using 3.1 xPONENT soware (Millipore); high
and low concentration quality controls were used with all the
biomarkers. The protein content in adipose tissue homogenates
was estimated by the Bradford method using a Bio-Rad protein
assay kit.2.7. Statistical analysis
All data were expressed as mean  standard deviation (SD).
Non-parametric signicant tests (Kruskal–Wallis one-way anal-
ysis of variance and Mann–Whitney U test) were performed to
compare values. Diﬀerences were considered statistically
signicant when p < 0.05, and in the Mann–Whitney U test the
signicance was adjusted with a Bonferroni test. Data were
analysed using statistical package SPSSv.19.0 soware (SPSS,
Institute Inc, Cary, NC).3. Results
3.1. Food intake, body weight gain and tissue weights
All diets provided equivalent amounts of carbohydrates and
proteins. However, cholesterol-rich diets led to an excess of
lipids resulting in 8.5 kcal per 100 g higher caloric intake.
During the 8-week study period, animals in the ve experi-
mental groups had similar daily food intake (approximately 20 g
per day).
Therefore, the groups consuming the cholesterol-rich diets
(Chol, HT, HT-Ac and HT-Et) presented a daily caloric excess of
approximately 2 kcal per day. However, this did not induce
signicant diﬀerences in the body weight gain compared with
the control animals, as can be seen in Table 2.This journal is © The Royal Society of Chemistry 2014
Fig. 1 Plasma lipid proﬁle (total cholesterol, LDL- and HDL-Chol) of
rats fed for 8 weeks with standard diet (C group), cholesterol-rich diet
(Chol group) and cholesterol-rich diet supplemented with hydrox-
ytyrosol (HT group), hydroxytyrosyl acetate (HT-Ac) and ethyl
hydroxytyrosyl ether (HT-Et). Data represent the means of 8 deter-
minations  SD. Bars without a common letter diﬀer, p < 0.05.
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View Article OnlineConsidering an average daily food intake of 20 g and an
average body weight of 300 g, the daily phenolic compound intake
was 25 mg kg1 body weight per day. This is a relatively low dose,
comparable with doses used in other studies8–11 and within a
range proven to elicit no toxic eﬀects in rats. Accordingly, no
pathologic alterations or behaviours were observed in the animals
during the study. Organs, including kidney or heart among
others, presented normal appearance by gross observation.
However, livers in animals fed the cholesterol-rich diet showed a
whitish appearance compared with the C group, suggestive of fat
accumulation, being signicantly heavier than those of the C
group (Table 2). Adipose tissue depots were obtained from retro-
peritoneal and epididymal areas, and when their weights were
normalized for the nal animal body weight, no diﬀerences were
observed among diﬀerent treatments. However, the ratio obtained
with the adipose tissue from the retroperitoneal area/epididymal
area showed signicant diﬀerences, being higher in the Chol and
HT groups than in the C group.
3.2. Plasma cholesterol prole
As shown in Fig. 1, animals fed the cholesterol-rich diet had a
marked hyperlipidaemia, with high LDL cholesterol and total
cholesterol concentrations, although HDL cholesterol levels
were not aﬀected as compared to the C group. Although not
reaching the values of control animals, supplementation of the
cholesterol-rich diet with 0.04% HT-Ac signicantly decreased
the total cholesterol and LDL cholesterol levels as compared
with the Chol group (p < 0.05), which was not attained in the HT
and HT-Et groups.
3.3. Biochemical parameters and hormones involved in
energy homeostasis
The high-cholesterol diet used in the present study induced a
signicant increase in glucose levels in the Chol group
compared to control animals (p < 0.05). All the tested phenolic
compounds counteracted the glucose increase, with a partial
eﬀect of HT-Et whereas values in HT-Ac and HT groups returned
to control levels (Table 3).
Triglyceride concentrations were similar in all groups,
although phenolic compound supplementation induced a
moderate yet non-signicant decrease. No diﬀerences were
observed in plasma concentrations of free fatty acids, whereas
creatinine concentrations were statistically higher in Chol and
HT groups, compared to C, HT-Ac and HT-Et groups (Table 3).
Aer consuming a high-cholesterol diet for 8 weeks, signif-
icant diﬀerences in plasma insulin and leptin concentrations
were observed in Chol compared to the C group. However, rats
consuming diets supplemented with HT and HT-Ac had
signicantly lower plasma insulin levels than Chol, decreasing
to control or even lower values as in the HT-Ac group (Table 3).
HT-Et also presented lower insulin levels than the Chol group
although not statistically diﬀerent (p ¼ 0.070), showing inter-
mediate values between Chol and C groups. Leptin levels were
lower in HT and HT-Et groups than in the Chol group, although
not reaching the level found in control animals. Again, the HT-
Ac group had signicantly lower plasma leptin levels than theThis journal is © The Royal Society of Chemistry 2014Chol group and in the range of control values. In the retroper-
itoneal adipose tissue, the leptin concentration was slightly
lower in all cholesterol-treated groups compared to the C
animals, although not signicantly diﬀerent.3.4. Redox status and inammatory biomarkers in blood
and tissue samples
Serum antioxidant activity (Table 4), analysed using the ORAC
assay, was lower in the Chol group compared to the controlFood Funct., 2014, 5, 1556–1563 | 1559
Table 3 Metabolic biomarkers in plasma and adipose tissue of rats in the control group (C), the group consuming the un-supplemented
cholesterol-rich diet (Chol) or the group fed the cholesterol-rich diet supplemented with hydroxytyrosol (HT), hydroxytyrosyl acetate (HT-Ac)
and ethyl hydroxytyrosyl ether (HT-Et). Data represent the mean of 8 determinations  SD*
Standard diet Hypercholesterolemic diet
C Chol HT HT-Ac HT-Et
Plasma biomarkers
Glucose (mg dL1) 140.50  15.23a 182.29  18.17b 143.25  19.83a 154.75  23.36a 160.00  22.53ab
Triglycerides (mg dL1) 106.71  21.69 100.29  18.33 83.00  29.50 90.50  19.49 84.57  13.90
Free fatty acids (mM equivalents
palmitic acid)
0.33  0.07 0.30  0.13 0.34  0.07 0.31  0.08 0.36  0.07
Creatinine (mg dL1) 0.52  0.02a 0.58  0.05b 0.55  0.02b 0.53  0.03a 0.53  0.03a
Hormones
Plasma Insulin (ng mL1) 972  341a 1560.2  997.9b 934.1  390a 608.1  301.6a 1121.3  617.1ab
Leptin (ng mL1) 2786  908a 4174  1116b 3609  1022ab 2970  1150a 3468.1  1291ab
Adipose tissue Leptin (ng mg1 pr) 682  189 501  178 503  137 503  148 671  283
* Mean values in a row with unlike superscripts are signicantly diﬀerent according to Kruskal–Wallis one-way analysis of variance and Mann–
Whitney U tests (p < 0.05).
Table 4 Redox status and inﬂammatory biomarkers in plasma and adipose tissue of rats fed the control diet (C), the un-supplemented
cholesterol-rich diet (Chol) and the cholesterol-rich diet supplemented with hydroxytyrosol (HT), hydroxytyrosyl acetate (HT-Ac) and ethyl
hydroxytyrosyl ether (HT-Et). Data represent the mean of 8 determinations  SD*
Standard diet Hypercholesterolemic diet
C Chol HT HT-Ac HT-Et
Antioxidant capacity Serum ORAC (mM T. eq.) 27.4  1.8ab 25.6  2.3a 28.4  1.6b 28.0  1.2b 26.2  1.1a
Lipid oxidation Serum (nmol mL1) 1.97  0.75a 3.54  0.24b 2.36  0.23a 2.19  0.39a 2.36  0.30a
Liver (nmol mg1 pr) 0.98  0.33a 3.33  1.14b 2.52  0.92bc 2.35  0.81bc 2.11  0.53c
Inammatory mediators Plasma TNFa (ng mL1) 3.0  0.7a 4.2  0.7b 3.7  0.8a 2.7  0.6a 3.4  0.7ab
IL-1b (ng mL1) 11.6  6.3 26.50  21.5 13.8  14.6 11.5  7.1 8.0  4.9
IL-6 (ng mL1) 4.9  4.4 3.66  1.63 6.0  3.3 5.7  3.7 5.9  2.4
Adipose tissue TNFa (ng mg1 pr) 2.5  0.6 2.2  0.5 2.2  0.5 2.0  0.4 1.9  0.3
IL-1b (ng mg1 pr) 3.9  0.9a 3.7  0.8a 3.8  0.6a 2.9  0.4b 3.1  0.2b
IL-6 (ng mg1 pr) 24.6  7.0 23.7  6.1 25.7  7.4 20  8 23.4  6.5
MCP-1 (ng mg1 pr) 32.3  7.4a 27.6  3.9a 28.5  3.9a 26  4b 25.6  3.4b
PAI-1 (ng mg1 pr) 87.6  22.9 98.9  32.9 92.4  15.4 73.3  18.0 81.5  12.4
* Mean values in a row with unlike superscripts are signicantly diﬀerent according to Kruskal–Wallis one-way analysis of variance and Mann–
Whitney U tests (p < 0.05).
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View Article Onlinegroup without reaching the level of statistical signicance.
However, rats fed with HT and HT-Ac diets showed a signi-
cantly higher serum antioxidant activity compared with the Chol
group (p < 0.05).
Regarding the biomarker of lipid peroxidation, the Chol
group showedMDA levels signicantly higher than C animals in
serum and liver (p < 0.05). Supplementation with any of the
studied phenolic compounds decreased MDA levels to control
values in serum (Table 4). However, although the three phenolic
compound-supplemented groups showed lower hepatic MDA
levels than the Chol group, diﬀerences were statistically signif-
icant only in the HT-Et group (p < 0.05) (Table 4).
Consuming the cholesterol-rich diet signicantly increased
the pro-inammatory cytokine TNFa plasma concentrations
compared to the C group, an eﬀect that was totally counteracted1560 | Food Funct., 2014, 5, 1556–1563by the three phenolic compounds (Table 4). A similar response
was observed with IL-1b, with increased values in the Chol
group returning to control levels in the HT, HT-Ac and HT-Et
animals, although diﬀerences did not reach the level of statis-
tical signicance (Table 4). Plasma IL-6 was not aﬀected by the
cholesterol-rich diet or the phenolic supplementation.
Cytokine concentrations in the visceral adipose tissue from
the retroperitoneal area of rats in the Chol group were similar to
those in the C group. TNFa and IL-6 concentrations were
unchanged in all the experimental groups; however, IL-1b
concentrations were lower in HT-Ac and HT-Et groups. Accord-
ingly, MCP-1 showed signicantly lower concentrations in HT-
Ac and HT-Et groups compared to the C group (Table 4). PAI-1
concentrations showed a similar tendency, but diﬀerences did
not reach statistical signicance.This journal is © The Royal Society of Chemistry 2014
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In the present study, the eﬀects of HT were studied in
comparison with HT-Ac and HT-Et, two lipophilic derivatives of
HT with a higher intestinal bioavailability than their
precursor.15,20 The evaluation of the biological properties of
these three compounds was performed, focusing on plasma
lipids, energy homeostasis and oxidative and inammatory
status in rats fed a cholesterol-rich diet. This study shows that
HT and its hydrophobic derivatives induce benecial metabolic
eﬀects in hypercholesterolemic rats. Particularly, HT-Ac showed
the highest capacity to counteract the metabolic stress induced
by the high-cholesterol diet.
Supplementation of diets with a moderate amount of
phenolic compounds (0.04%) resulted in a daily intake of 25 mg
kg1 body weight, which is far beyond any possible toxic level
considering a recently published study where consumption of
up to 500 mg kg1 per day was described as a No Observed
Adverse Eﬀects Level (NOAEL).30
As expected, feeding rats with a diet rich in cholesterol
resulted in an increase in total cholesterol and LDL cholesterol
levels. In this hypercholesterolemic model, HT and HT-Et
showed modest plasma LDL cholesterol lowering eﬀects, in
contrast to HT-Ac that showed signicantly reduced total and
LDL cholesterol levels compared to the Chol group. These
results are in line with previous human and animal studies
showing that phenolic compounds present in virgin olive oil
exert benecial cardiovascular eﬀects, particularly improving
the lipid prole.8,10,31 In fact, the European Food Safety Authority
has recently issued a positive opinion on the capacity of olive oil
phenolic compounds to protect LDL cholesterol from oxidative
damage.32
Several markers show that rats in the present study suﬀered
hepatic stress induced by the cholesterol-rich diet, which may
have led to an incipient insulin resistance.2 Comparing the Chol
and C groups, the high-cholesterol diet induced a signicant
increase in glucose, creatinine, insulin and leptin plasma
concentrations. In addition, Chol hypercholesterolemic animals
presented higher liver weights than C animals and the adipose
depots were mainly distributed in the retroperitoneal area.
Interestingly, the diets supplemented with phenolic
compounds counteracted the glucose and insulin increase,
particularly HT and HT-Ac. This outcome is in accordance with
previous studies showing that HT and other olive oil phenolic
compounds reduce the plasma glucose concentration in
alloxan-diabetic rats8,9 by means of alleviating oxidative stress
and free radicals as well as enhancing enzymatic defence. A
recent paper evidenced the role of oleuropein aglycone in the
prevention of cytotoxic amyloid aggregation of human amylin, a
hallmark of Type-II diabetes.33 In accordance, the PREDIMED
study showed that consuming a virgin olive oil-enriched tradi-
tional Mediterranean diet for three months decreased total and
LDL cholesterol together with plasma glucose in asymptomatic
high cardiovascular-risk patients, although no changes were
observed in insulin levels.34 In line with these results, a signif-
icant decrease of glycaemia related to long term daily intake of aThis journal is © The Royal Society of Chemistry 2014virgin olive oil rich in phenolic compounds was observed in
healthy young subjects.35 HT-Ac also maintained plasma leptin
at concentrations similar to those in the C group, while this
eﬀect was more discrete in the case of HT and HT-Et. Similarly,
in rats that consumed the diet supplemented with HT-Ac and
HT-Et creatinine concentrations were restored to control levels,
but not in rats that consumed a diet supplemented with HT.
The renal protective eﬀect of olive phenols reducing creatinine
levels has already been described in diabetic rats.8
The retroperitoneal/epididymal fat ratio provides informa-
tion about adipose tissue distribution, being directly propor-
tional to the abdominal fat accumulation. Both retroperitoneal
and epididymal adipose depots are considered visceral fat
associated with higher levels of inammation and lipolysis than
subcutaneous fat, being related to insulin resistance.36 The
retroperitoneal adipose depots in rats could be related to
abdominal adiposity in humans since they are located inside
the peritoneum attached to the dorsal area of the abdomen,
whereas epididymal adipose tissue would correspond to
gonadal fat, which exists in mice and rats but not in humans.
The groups supplemented with lipophilic compounds (HT-Ac
and HT-Et) moderately improved the retroperitoneal/epidid-
ymal fat ratio compared to the Chol group, whereas the group
that consumed HT did not show changes. Our results are in
agreement with the reduction in abdominal fat deposition
described in a metabolic syndrome animal model that
consumed a diet supplemented with an olive leaf extract rich in
HT.37
Metabolic disturbance which includes hyperlipidaemia,
hyperglycaemia and hyperinsulinemia oen involves chronic
inammation and oxidative stress.2,8,11 Therefore, redox status
and inammatory biomarkers were analyzed in plasma in order
to understand the potential mechanisms underlying the eﬀects
of the studied phenolic compounds. Although the possible
health implications related to MDA changes remain unknown,
in this study elevated systemic MDA concentrations were
observed in the Chol group, suggesting a marked oxidative
stress in these animals that was counteracted by the
consumption of the phenolic compounds. Moreover, the serum
antioxidant capacity of animals consuming the phenolic
compounds was higher than in the Chol group, particularly HT
and HT-Ac. However, at the hepatic level phenolic compounds
supplementation did not decrease MDA levels to control values
although hepatic peroxidation was reduced in all cases, espe-
cially in the HT-Et group (Table 4). It is noteworthy that the
studied phenolic compounds follow diﬀerent metabolic path-
ways when ingested. HT-Ac is extensively hydrolysed into free
HT, whereas HT-Et remains unaltered, yielding more lipophilic
metabolites than those generated aer HT and HT-Ac hepatic
metabolism.15,20 This would result in higher HT-Et bio-
accumulation in hepatic tissue, conferring higher protection
against oxidation than HT and HT-Ac metabolites.
The protective role of olive oil phenolic compounds against
oxidative damage is well established and has been reviewed
recently.1 The antioxidant and free radical scavenging capacity
of olive oil phenols seem to be related to their anti-inamma-
tory eﬀects, which have been reported in diﬀerent animalFood Funct., 2014, 5, 1556–1563 | 1561
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View Article Onlinemodels.38,39 Gong, Geng, Jiang, Cao, Yoshimura & Zhong40
showed the capacity of HT to decrease the pro-inammatory
cytokines IL-1b and TNFa but not to increase the anti-inam-
matory cytokine IL-10 in carrageenan-induced acute inam-
mation and hyperalgesia in rats. Moreover, the role of olive oil
phenols in reducing the postprandial inammatory response in
obese subjects has been recently attributed to the inhibition of
NF-kB, which is an important link between oxidation and
inammation in the postprandial state.41 In the present study,
diets supplemented with HT, HT-Ac and HT-Et had anti-
inammatory eﬀects, decreasing plasma TNFa in rats fed a
cholesterol-rich diet. Similar behaviour was observed with IL-1b
although not reaching statistical signicance probably due to
the high variability that this parameter presented in the Chol
group. In adipose tissue, supplementation with HT-Ac and HT-
Et decreased MCP-1 and IL-1b below control levels.
Nutrients' mechanisms of action are strongly related to the
capacity to modulate gene expression. Llorente-Cortes and co-
workers34 showed that consuming a traditional Mediterranean
diet enriched with virgin olive oil for three months improved
the lipid prole and plasma glucose levels, prevented the
increased expression of cyclooxigenase-2 (COX2) and LDL
receptor-related protein-1 (LRP-1) genes, and reduced the
expression of MCP1 gene compared with a traditional Medi-
terranean diet enriched with nuts or with a low fat diet. COX2
and MCP1 genes are involved in inammation whereas LRP1
takes part in foam cell formation. Likewise, Konstantinidou and
co-workers31 observed lower plasma oxidative and inammatory
status in healthy subjects aer consuming for three months a
Mediterranean diet supplemented with virgin olive oil rich in
phenolic compounds compared to the control group. In the
study, pro-atherogenic genes related to inammation (IFNg,
ARHGAP15 and IL7R) and oxidative stress (ADRB2) were down-
regulated in peripheral blood mononuclear cells (PBMCs).
Changes in gene expression were associated with decreases in
lipid oxidative damage and systemic inammation markers. In
vitro studies have established the capacity of HT to modulate
adipocyte lipid content and gene expression partially mediated
by the reduction of the transcription factors PPARa and C/
EBPa.42 In phytochemicals' capacity to modify gene expression
in diﬀerent tissues and cell lines, the chemical structure of the
phytochemical plays an important role not only in their direct
scavenging of free radicals, but also in the target protein and
therefore in the molecular mechanism involved in its biological
action. Thus, considering the extensive hydrolysis that HT-Ac
undergoes during intestinal absorption yielding HT,15 both
compounds could follow similar mechanisms to regulate the
imbalance induced by the high-cholesterol rich diet. Our results
suggest changes in the expression of redox and inammatory
related genes, based on studies recently published by other
research groups; however, further work is required to elucidate
the molecular mechanisms underlying the regulatory metabolic
eﬀect of HT and its derivatives.
A limitation of this study is that a control group fed a stan-
dard diet supplemented with HT was not included to assess the
eﬀect of this compound within a balanced diet in healthy
animals.1562 | Food Funct., 2014, 5, 1556–1563In summary, HT and its lipophilic derivatives, HT-Ac and
HT-Et, were able to reduce the metabolic imbalance induced by
a high-cholesterol diet in rats, with HT-Ac, the lipophilic HT
derivative naturally present in virgin olive oil, being the most
eﬀective phenolic compound. Since HT-Ac can be easily
obtained from natural HT,12 this compound might be proposed
as an interesting bioactive ingredient in the production of
functional foods, having the added value of contributing to
induce benecial metabolic properties.
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